ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ALEC Alector Inc

4.26
0.00 (0.00%)
Pre Market
Last Updated: 03:05:31
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 3.54
Ask Price 6.81
News -
Share Name Share Symbol Market Stock Type
Alector Inc ALEC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 4.26 03:05:31
Open Price Low Price High Price Close Price Previous Close
4.26
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0 US$ 4.26 USD

Alector Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
407.89M 95.75M - 97.06M -130.39M -1.36 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Alector News

Date Time Source News Article
6/12/202415:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/12/202415:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/12/202415:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/12/202415:45Edgar (US Regulatory)Form 8-K - Current report
6/10/202406:00GlobeNewswire Inc.Alector to Host Virtual Research and Development Event..
6/04/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/04/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/04/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/04/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/03/202406:00GlobeNewswire Inc.Alector to Participate in the Goldman Sachs 45th Annual..
5/31/202420:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/31/202420:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ALEC Message Board. Create One! See More Posts on ALEC Message Board See More Message Board Posts

Historical ALEC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Alector Description

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101.

Your Recent History

Delayed Upgrade Clock